The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern

Thiru PrasannaDepartment of Medical Oncology, The Canberra Hospital, Garran, Canberra, Australia; Correspondence[email protected]

http://orcid.org/0000-0002-8745-8879

Christos S. KarapetisDepartment of Medical Oncology, Flinders Medical Centre, Bedford Park, Australia; ;Flinders Clinical and Molecular Medicine, Surgery, Flinders University, Bedford Park, Australia;

David RoderSouth Australian Health & Medical Research Institute (SAHMRI), Adelaide, Australia; ;School of Health Sciences, University of South Australia, Adelaide, Australia;

http://orcid.org/0000-0001-6442-4409

Jeanne TieDepartment of Medical Oncology, Western Hospital, Melbourne, Australia; ;Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; ;Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia;

Robert PadburyFlinders Clinical and Molecular Medicine, Surgery, Flinders University, Bedford Park, Australia; ;Department of Surgery, Flinders Medical Centre, Adelaide, Australia;

Timothy PriceThe Queen Elizabeth Hospital and University of Adelaide, Adelaide, Australia;

Rachel WongWalter and Eliza Hall Institute of Medical Research, Melbourne, Australia; ;Department of Medical Oncology, Eastern Health, Melbourne, Australia; ;Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia;

Jeremy ShapiroCabrini Haematology and Oncology Centre, Melbourne, Australia;

Louise NottDepartment of Medical Oncology, Royal Hobart Hospital, Tasmania, Australia; ;Menzies Research Institute, Hobart, Australia;

Margaret LeeWalter and Eliza Hall Institute of Medical Research, Melbourne, Australia; ;Department of Medical Oncology, Eastern Health, Melbourne, Australia;

Yu Jo ChuaDepartment of Medical Oncology, The Canberra Hospital, Garran, Canberra, Australia; ;ANU Medical School, Australian National University, Canberra, Australia;

Paul CraftDepartment of Medical Oncology, The Canberra Hospital, Garran, Canberra, Australia; ;ANU Medical School, Australian National University, Canberra, Australia;

Cynthia PiantadosiFlinders Centre for Innovation in Cancer, Bedford Park, Australia;

Michael SorichCollege of Medicine and Public Health, Flinders University, Adelaide, Australia

Peter GibbsDepartment of Medical Oncology, Western Hospital, Melbourne, Australia; ;Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia;

Desmond YipDepartment of Medical Oncology, The Canberra Hospital, Garran, Canberra, Australia; ;ANU Medical School, Australian National University, Canberra, Australia;

show all

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern

Supplemental Material

Related Research Data

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

The survival outcome of patients with metastatic colorectal cancer based on the site of metastases and the impact of molecular markers and site of primary cancer on metastatic pattern

Supplemental Material

Reprints and Corporate Permissions

Academic Permissions

Related Research Data

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date